Media Giants Battle: Alternative Platforms Poised To Capitalize
This carefully selected group of stocks represents media companies positioned to benefit from the fallout of Trump's $10B lawsuit against News Corp. Our professional analysts have identified these platforms as potential winners in the shifting media landscape, ready to capture new audiences and advertising revenue.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
Trump's lawsuit against News Corp creates a rare market disruption that could redirect audience attention and advertising dollars. This collection targets companies across traditional broadcasting, streaming, social media, and digital content that stand to capture market share during this unprecedented media industry upheaval.
What You Need to Know
This diverse media portfolio includes established giants like Disney and Warner Bros Discovery alongside emerging platforms such as Reddit and Pinterest. These companies represent various channels through which audiences consume news and entertainment, potentially benefiting from shifts in viewer loyalty.
Why These Stocks
These companies were selected for their positioning as alternatives to News Corp properties. They include direct competitors in news distribution, entertainment programming, and advertising monetization that could attract displaced audiences and advertisers looking to reallocate their media spending during this legal battle.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+29.45%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 29.45% over the next year.
Stocks Rated Buy by Analysts
12 of 16 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.1% return last month.
Why You'll Want to Watch These Stocks
Audience Shifting Now
Trump's $10B lawsuit is already causing viewers to reconsider their news sources. These alternative platforms stand ready to welcome these shifting audiences and the advertising dollars that follow them.
Ad Revenue Up for Grabs
Advertisers are carefully reconsidering their media placements in light of this high-profile legal battle. Companies in this group are perfectly positioned to capture redirected advertising budgets worth billions.
Unprecedented Media Disruption
This lawsuit represents a once-in-a-generation disruption to the established media order. Media companies outside the News Corp umbrella have a rare opportunity to gain substantial market share during this industry-shaking event.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.